Index
RUT
Market Cap
110.69M
Enterprise Value
110.30M
Income
-19.24M
Sales
88.34M
Book/sh
0.47
Cash/sh
0.66
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
146
IPO
Apr 22, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
1.25
P/B
2.16
P/C
1.52
P/FCF
-
EV/EBITDA
-
EV/Sales
1.25
Quick Ratio
2.75
Current Ratio
2.81
Debt/Eq
1.41
LT Debt/Eq
1.12
Option/Short
Yes / Yes
EPS (ttm)
-0.20
EPS next Y
-0.29
EPS next Q
-0.07
EPS this Y
26.86%
EPS next Y
20.70%
EPS next 5Y
32.32%
EPS past 3/5Y
0.62% -4.52%
Sales past 3/5Y
-20.22% 0.38%
EPS Y/Y TTM
73.74%
Sales Y/Y TTM
66.89%
EPS Q/Q
65.12%
Sales Q/Q
123.95%
Insider Own
7.11%
Insider Trans
-0.35%
Inst Own
68.88%
Inst Trans
7.40%
ROA
-14.35%
ROE
-42.85%
ROIC
-17.69%
Gross Margin
81.28%
Oper. Margin
-14.42%
Profit Margin
-21.77%
SMA20
-8.60%
SMA50
-19.38%
SMA200
-43.40%
Trades
Shs Outstand
109.52M
Shs Float
101.81M
52W High
2.98 -66.11%
52W Low
0.90 12.22%
Volatility
9.58% 8.45%
ATR (14)
0.10
RSI (14)
41.32
Beta
2.36
Rel Volume
2.27
Avg Volume
911.76K
Volume
2,067,438
Perf Week
-12.93%
Perf Month
-22.90%
Perf Quarter
-39.16%
Perf Half Y
-59.44%
Perf YTD
-38.04%
Perf Year
-35.67%
Perf 3Y
-49.25%
Perf 5Y
-97.29%
Perf 10Y
-79.80%
Prev Close
1.05
Price
1.01
Change %
-3.81%
Analysts 11 incl. previous ratings
Rating Distribution 8 Buy · 3 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 19, 2024 Downgrade T The Benchmark Company
Buy → Hold Jun 03, 2024 Resumed J Jefferies
Buy $5 +395.0% May 30, 2024 Initiated C Cantor Fitzgerald
Overweight $11 +989.1% Feb 29, 2024 Upgrade T The Benchmark Company
Hold → Buy Nov 07, 2023 Downgrade T The Benchmark Company
Buy → Hold Aug 07, 2023 Downgrade T TD Cowen
Outperform → Market Perform $21 → $4 +296.0% May 09, 2023 Downgrade H H.C. Wainwright
Buy → Neutral Mar 31, 2022 Resumed P Piper Sandler
Overweight $35 +3,365.3% Mar 02, 2022 Resumed C Cowen
Outperform Apr 12, 2021 Initiated P Piper Sandler
Overweight $32 +3,068.3% Mar 01, 2021 Initiated S Stifel
Buy $30 +2,870.3% Feb 26, 2021 Reiterated H H.C. Wainwright
Buy $21 → $26 +2,474.3% Mar 10, 2020 Initiated T The Benchmark Company
Buy Jan 17, 2019 Upgrade F First Analysis Sec
Neutral → Outperform $12 → $19 +1,781.2% May 16, 2018 Initiated S Stephens
Overweight $16 +1,484.2% Oct 13, 2017 Reiterated H H.C. Wainwright
Buy $8 → $8.50 +741.6% May 31, 2017 Initiated J Jefferies
Buy $8 +692.1% Jan 26, 2017 Downgrade F First Analysis Sec
Overweight → Equal-Weight $5.50 +444.6% Jan 04, 2017 Upgrade L Ladenburg Thalmann
Neutral → Buy Jan 06, 2016 Initiated H H.C. Wainwright
Buy $6 +494.1%
Show Previous Ratings
Nov-19-26 06:00AM
Nov-12-26 06:44PM
(Earnings Whispers)
+21.07%
04:32PM
04:05PM
Nov-10-26 06:00AM
06:00AM
Loading…
Nov-09-26 06:00AM
Nov-04-26 04:48PM
(Earnings Whispers)
-5.56%
Oct-29-26 09:00AM
Sep-28-26 06:00AM
Sep-25-26 06:29PM
Aug-27-26 09:00AM
Aug-12-26 01:02AM
Aug-11-26 04:42PM
04:05PM
Aug-03-26 09:00AM
09:00AM
Loading…
Jul-28-26 09:00AM
Jul-23-26 11:47PM
(GlobeNewswire)
-3.40%
-25.63%
04:13PM
May-20-26 09:00AM
May-07-26 05:34PM
(Associated Press)
-3.01%
+10.47%
04:05PM
Apr-29-26 09:00AM
Apr-23-26 09:00AM
Mar-11-26 11:01PM
04:37PM
(Associated Press Finance)
04:05PM
Mar-07-26 08:03PM
Mar-05-26 07:45AM
Mar-04-26 10:06AM
Feb-26-26 09:55AM
09:00AM
Loading…
Feb-25-26 09:00AM
Feb-24-26 08:50AM
Feb-17-26 09:00AM
Feb-10-26 09:00AM
08:15AM
Jan-07-26 09:00AM
Nov-11-25 09:35AM
Nov-10-25 09:00AM
Nov-07-25 12:02AM
Nov-06-25 08:00PM
06:55PM
(Associated Press Finance)
04:21PM
Nov-05-25 08:15AM
Nov-04-25 05:55PM
Oct-29-25 09:58AM
Oct-23-25 07:05AM
Aug-28-25 09:00AM
Aug-14-25 03:12AM
Aug-13-25 05:15PM
04:23PM
(Associated Press Finance)
04:05PM
07:30AM
Aug-12-25 03:00PM
Aug-11-25 08:10AM
Aug-07-25 07:30AM
Aug-04-25 05:15PM
Aug-01-25 07:45AM
Jul-30-25 04:05PM
May-22-25 07:00AM
May-21-25 04:05PM
May-15-25 01:03PM
(Thomson Reuters StreetEvents)
03:15AM
May-14-25 05:40PM
04:39PM
(Associated Press Finance)
04:05PM
May-13-25 05:10PM
May-12-25 05:45PM
May-07-25 07:00AM
Apr-30-25 04:05PM
Apr-24-25 10:01AM
08:15AM
Apr-09-25 05:00PM
Apr-03-25 10:01AM
Apr-01-25 07:00AM
Mar-24-25 07:00AM
Mar-07-25 04:05PM
(GlobeNewswire)
+3.30%
-6.74%
Feb-28-25 11:02AM
(Thomson Reuters StreetEvents)
-22.65%
02:36AM
Feb-27-25 06:35PM
05:36PM
(Associated Press Finance)
04:05PM
Feb-18-25 04:05PM
Feb-14-25 05:15PM
Feb-13-25 04:05PM
Feb-06-25 04:05PM
Jan-16-25 04:05PM
Jan-10-25 04:05PM
Dec-06-24 04:05PM
Nov-19-24 04:05PM
Nov-14-24 04:05PM
(GlobeNewswire)
-7.43%
+3.74%
Nov-12-24 04:05PM
04:05PM
Nov-11-24 04:05PM
Nov-08-24 04:05PM
Nov-04-24 04:05PM
Nov-01-24 09:01AM
Oct-31-24 05:30PM
04:23PM
(Associated Press Finance)
04:05PM
Oct-24-24 04:05PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MOORE ALISON President and CEO Nov 16 '26 Sale 1.14 10,651 12,111 233,520 Nov 18 04:30 PM MOORE ALISON Officer Nov 16 '26 Proposed Sale 1.14 10,651 12,111 Nov 16 09:37 PM De Vre Raymond Director Nov 09 '26 Sale 1.11 1,088 1,208 83,723 Nov 10 04:05 PM Erbez Georgia See Remarks Oct 12 '26 Sale 1.36 6,335 8,619 60,475 Oct 14 05:19 PM MOORE ALISON President and CEO Oct 12 '26 Sale 1.36 6,335 8,619 244,171 Oct 14 05:17 PM Erbez Georgia Officer Oct 12 '26 Proposed Sale 1.36 6,335 8,619 Oct 13 04:32 PM MOORE ALISON Officer Oct 12 '26 Proposed Sale 1.36 6,335 8,619 Oct 13 04:27 PM De Vre Raymond Director Jun 11 '26 Sale 2.37 2,605 6,174 84,811 Jun 11 08:19 PM Lutz Stefan Chief Scientific Officer Feb 24 '26 Sale 1.13 5,862 6,641 130,421 Feb 25 07:54 PM Lutz Stefan Officer Feb 24 '26 Proposed Sale 1.17 5,280 6,178 Feb 23 08:08 PM Lutz Stefan Chief Scientific Officer Feb 06 '26 Sale 1.31 2,492 3,257 136,283 Feb 09 04:07 PM Erbez Georgia See Remarks Feb 06 '26 Sale 1.31 3,826 5,001 66,810 Feb 09 04:07 PM MOORE ALISON President and CEO Feb 06 '26 Sale 1.31 3,826 5,001 250,506 Feb 09 04:06 PM Norrett Kevin Officer Feb 06 '26 Proposed Sale 1.27 3,291 4,180 Feb 06 06:18 PM Lutz Stefan Officer Feb 06 '26 Proposed Sale 1.27 2,460 3,124 Feb 06 06:15 PM KEVIN NORRETT Officer Jan 16 '26 Proposed Sale 1.67 1,745 2,914 Jan 16 05:09 PM Lutz Stefan CSO Jan 07 '26 Sale 1.70 4,685 7,950 138,775 Jan 08 06:51 PM Norrett Kevin Officer Jan 07 '26 Proposed Sale 1.70 6,123 10,409 Jan 07 09:17 PM Opaleye Management Inc. 10% Owner Dec 01 '25 Sale 1.67 253,533 422,766 179,989 Dec 01 05:41 PM Opaleye Management Inc. 10% Owner Nov 28 '25 Sale 1.75 107,490 188,108 188,522 Dec 01 05:41 PM Opaleye Management Inc. 10% Owner Nov 26 '25 Sale 1.74 5,000 8,706 191,012 Dec 01 05:41 PM
Codexis, Inc. is an enzyme engineering company, which engages in technology solutions to improve therapeutics manufacturing. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
President Dr. Alison Moore Ph.D.
CFO & Chief Business Officer Ms. Georgia L. Erbez
Chief Scientific Officer Dr. Stefan Lutz Ph.D.
Senior Vice President of Sales & Marketing Mr. Britton Jimenez
Senior VP & Head of Human Resources Ms. Karen Frechou-Armijo